Advertisements

Stocking Stuffers

 

Biocept Inc. (BIOC) Stock Quote

Detailed Quote for Biocept Inc. (BIOC)
$ 0.342   -0.012 (-3.39%) Volume: 3.86m 4:00 PM EST Jan 22, 2020
After Hours:  $ 0.33   -0.012 (-3.51%) Volume: 141.94k 7:59 PM EST Jan 22, 2020
Today 5d 1m 3m 1y more
Last Price
0.342
Change $
0.012
Change %
3.39%
Tick
  
Bid
0.3301
Bid Size
100
Ask
0.365
Ask Size
500
Open
0.353
High
0.353
Low
0.33
Prev Close
0.354
Last Trade
01/22/20
Volume
3.86m
52 Wk Hi
2.50
52 Wk Low
0.227500006
Market Cap
14.44m
Ex-Div Date
N/A
Div Rate
N/A
Yield
N/A
Shares
42,218,235
EPS (TTM)
-1.98000001
PE Ratio
N/A
Exchange
NCM
News and Media for Biocept Inc. (BIOC)
Sector News | Topic News
News for Biocept Inc. (BIOC)
Tue, Jan 14, 2020
12:14 PM Top Penny Stocks To Watch Right Now; 1 Up Over 100% Since November - PennyStocks.com
8:05 AM Biocept Announces Validation and Availability of its Liquid Biopsy Platform for the Detection of Actionable Cancer Biomarkers in Cerebrospinal Fluid - PR Newswire
Wed, Jan 08, 2020
9:00 AM Biocept, Inc. Awarded United States Patent for the Use of Antibodies in Combination with Any Solid Surface to Detect Any Target Cell of Interest - from Any Sample Type - PR Newswire
Thu, Dec 12, 2019
8:00 AM Biocept Announces Closing of $10.0 Million Underwritten Public Offering - PR Newswire
Mon, Dec 09, 2019
9:58 AM Biocept prices equity offering, shares down 52% - SeekingAlpha
9:15 AM Biocept Announces Pricing of $10.0 Million Underwritten Public Offering - PR Newswire
Fri, Dec 06, 2019
9:50 AM Key events next week - healthcare - SeekingAlpha
Tue, Dec 03, 2019
8:05 AM Biocept's Liquid Biopsy CTC Testing for Breast Cancer to Be Featured in Poster Presentation at the 2019 San Antonio Breast Cancer Symposium\u00AE - PR Newswire
Thu, Nov 21, 2019
8:12 AM Biocept launches new liquid biopsy test - SeekingAlpha
8:05 AM Biocept Announces the Launch of its Liquid Biopsy Test to Detect TRK Biomarkers in the Blood of Patients Diagnosed with Cancer - PR Newswire
Wed, Nov 13, 2019
9:58 PM Biocept, Inc. (BIOC) CEO Michael Nall on Q3 2019 Results - Earnings Call Transcript - SeekingAlpha
4:10 PM Biocept EPS beats by $0.02, beats on revenue - SeekingAlpha
4:05 PM Biocept Reports Third Quarter 2019 Financial Results - PR Newswire
Thu, Nov 07, 2019
8:05 AM Biocept Announces CE IVD Marks and Availability of its CEE-Sure\u00AE Blood Collection Tube and Sample Collection Shipping Kit in Europe - PR Newswire
Wed, Nov 06, 2019
8:05 AM Biocept to Release Third Quarter 2019 Financial Results and Host Investor Conference Call on November 13, 2019 - PR Newswire
Mon, Nov 04, 2019
8:05 AM Biocept's Target Selector(TM) Tests and Kits to Be Featured in Six Poster Presentations at the 2019 Association for Molecular Pathology Annual Meeting - PR Newswire
More News for BIOC >>
Filings for Biocept Inc. (BIOC)
Fri, Nov 15, 2019
3:00 AM [Amend] General form for registration of securities under the Securities Act of 1933 - Form S-1/A
Wed, Nov 13, 2019
3:00 AM Current report pursuant to Section 13 or 15(d) - Form 8-K
3:00 AM General form for quarterly reports under Section 13 or 15(d) - Form 10-Q
Fri, Nov 08, 2019
3:00 AM [Amend] General form for registration of securities under the Securities Act of 1933 - Form S-1/A
More Filings for BIOC >>

Tags for Biocept Inc.

Research stocks or mutual funds related to Biocept Inc. by keywords or tags. Find companies that have a similar focus to BIOC. The keywords below have been associated to BIOC by either user submission or electronic means.